Improvement in lung fibrosis using intravenous immunoglobulin in systemic sclerosis with myositis

Scand J Rheumatol. 2014;43(2):170-1. doi: 10.3109/03009742.2013.868510. Epub 2014 Feb 6.

Authors

W Mauhin¹, S Rivière, J Cabane, K P Tiev

Affiliation

¹ Department of Internal Medicine, Saint-Antoine Hospital, Paris VI University. The Public Assistance Hospitals of Paris (AH-HP) , Paris.

PMID: 24588337
DOI: 10.3109/03009742.2013.868510

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Comorbidity
Female
Humans
Immunoglobulins, Intravenous / therapeutic use*
Lung / diagnostic imaging
Lung / pathology
Middle Aged
Myositis / drug therapy*
Myositis / epidemiology
Pulmonary Fibrosis / drug therapy*
Pulmonary Fibrosis / epidemiology
Scleroderma, Systemic / drug therapy*
Scleroderma, Systemic / epidemiology
Tomography, X-Ray Computed
Treatment Outcome

Substances

Immunoglobulins, Intravenous